According to a survey conducted by Bain &, Company, 75 % of healthcare providers are now investing more in artificial intelligence ( AI), cybersecurity, and other IT fields. What started out as a temporary reaction to the pandemic has since become a defining feature of the next-generation healthcare, thanks to the swift integration of relational AI technologies.
Healthcare IT is projected to grow by 15.4 % between 2024 and 2031, making it a very attractive investment opportunity for property market participants.
Verified market study is the picture cause
The integration of AI and care has taken a significant step forward in 2025, among different modalities. With a particular emphasis on platforms that combine scientific data, scanning, genomics, and real-world data, venture capitalists and institutional investors are transferring capital into health technology.
Tempus AI TEM, one of the most talked-about participants of this pattern, has increased its share by 30 % year over year. The company is integrating multi-modal data ( genomics, pathology, radiology, and EMRs ) to inform clinical decisions while revolutionizing precision oncology and personalized care through its proprietary AI-based platform. Tempus AI has expanded its footprint in both oncology and rare disease analysis in 2025, following its substantial investment in Deep 6 AI and new partnerships with a number of health systems.
But, Tempus AI is not the only company to pique the interest of investors. AI-driven medical organizations like Butterfly Network BFLY and Health Catalyst HCAT have the credentials to rise as the next big players because of their rapid development, increased FDA certifications, and growing healthcare cost problems.
In terms of going electric, care is catching up with various industries. According to Deloitte, 70 % of officials plan to invest in digital devices in 2025, and 60 % want to improve core technology like EMRs and ERP application, despite facilities still using dated devices like fax machines and manual data entry. About 90 % of executives anticipate that digital technologies will advance more quickly in 2025, with 50 % of those who predict significant changes.
Another important area of focus in 2025 is security. As modern adoption grows, so does the risk of digital threats. 78 % of executives are giving cybersecurity improvements a priority in 2025, acknowledging that future problems are not a probability but a near certainty.
More than 40 % of agencies report significant-to-moderate return on investment, according to Deloitte, and this is already demonstrating its worth for a sizable percentage of organizations. 37 % of respondents believe it’s too early to tell, which suggests that many businesses are still in the early stages of implementation or evaluation.
Deloitte as the photo source
With its amazing Ultrasound-on-Chip semiconductor technology and ultrasonic software solutions, Butterfly Network, a digital imaging company, is becoming well-known. Butterfly introduced the first ever handheld, single-probe, whole-body sonar program, Butterfly intelligence, in 2018. In 2020 and 2024, iQ+ and iQ3 were followed by them, each using Moore’s Rules to improve their control strength and performance. To promote the adoption of cheap, available scanning, Butterfly Network combines advanced technology, smart program, AI, services, and education.
This Zacks Rank# 2 ( Buy ) business is anticipated to experience 5.9 % earnings growth on an 18.9 % increase in revenues in 2025. In each of the last four quarters, Butterfly Network exceeded earnings expectations, with a 32.9 % surprise in the trailing four-quarter average. Over the past three months, Butterfly Network has maintained an average brokerage recommendation ( ABR ) of 1.00 on a scale of 1 to 5 ( Strong Buy to Strong Sell ).
Zacks Investment Research Image Source
This business is known as Health Catalyst, and its products and services aim to enable the development of measurable clinical, financial, and operational improvement. More than 1, 000 businesses around the world rely on Health Catalyst‘s offerings, including its cloud-based technology ecosystem Health Catalyst Ignite, AI-enabled data and analytics solutions, and expert services to deliver meaningful outcomes across hundreds of millions of patient records.
This Zacks Rank# 3 ( Hold ) stock is expected to experience 7.1 % earnings growth in 2025 on a 9.2 % increase in revenues. The expected earnings growth rate for 2026 for Health Catalyst is set at 38.3 %. HCAT currently has a 1.67 ABR. The full list of today’s Zacks# 1 Rank ( Strong Buy ) stocks can be seen here.
Zacks Investment Research Image Source
Want the most recent recommendations from Zacks Investment Research? You can download the 7 Best Stocks for the upcoming 30 days as of right now. Click here to download this free report